The toxicity of dopamine antagonists is typically evaluated through animal studies and clinical trials. These studies help determine the therapeutic index, which is the ratio of the drug's toxic dose to its effective dose. A higher therapeutic index indicates a safer drug. Additionally, post-marketing surveillance helps identify adverse effects that may not have been evident in initial studies.
